[HTML] sciencedirect.com

[HTML][HTML] Optimizing the conditioning regimen for hematopoietic cell transplant in myelofibrosis: long-term results of a prospective phase II clinical trial

U Popat, RS Mehta, R Bassett, P Kongtim… - Biology of Blood and …, 2020 - Elsevier
Optimal conditioning regimens for older patients with myelofibrosis undergoing allogeneic
hematopoietic cell transplant are not known. Likewise, the role of dose intensity is not clear …
被引用次数：18 相关文章
[HTML] astctjournal.org

[HTML][HTML] Optimizing the Conditioning Regimen for Hematopoietic Cell Transplant in Myelofibrosis: Long-Term Results of a Prospective Phase II Clinical Trial

U Popat, RS Mehta, R Bassett, P Kongtim… - Biology of Blood and …, 2020 - astctjournal.org
Optimal conditioning regimens for older patients with myelofibrosis undergoing allogeneic
hematopoietic cell transplant are not known. Likewise, the role of dose intensity is not clear …

Optimizing the Conditioning Regimen for Hematopoietic Cell Transplant in Myelofibrosis: Long-Term Results of a Prospective Phase II Clinical Trial

U Popat, RS Mehta, R Bassett… - Biology of blood …, 2020 - pubmed.ncbi.nlm.nih.gov
Optimal conditioning regimens for older patients with myelofibrosis undergoing allogeneic
hematopoietic cell transplant are not known. Likewise, the role of dose intensity is not clear …

Optimizing the Conditioning Regimen for Hematopoietic Cell Transplant in Myelofibrosis: Long-Term Results of a Prospective Phase II Clinical Trial.

U Popat, RS Mehta, R Bassett, P Kongtim… - Biology of Blood and …, 2020 - europepmc.org
Background: Optimal conditioning regimen for older patients with myelofibrosis undergoing
allogeneic hematopoietic cell transplantation (HCT) is not known. Likewise, role of dose …

Optimizing the Conditioning Regimen for Hematopoietic Cell Transplant in Myelofibrosis: Long-Term Results of a Prospective Phase II Clinical Trial

U Popat, RS Mehta, R Bassett… - Biology of Blood …, 2020 - mdanderson.elsevierpure.com
Optimal conditioning regimens for older patients with myelofibrosis undergoing allogeneic
hematopoietic cell transplant are not known. Likewise, the role of dose intensity is not clear …
[HTML] nih.gov

[HTML][HTML] Optimizing the Conditioning Regimen for HCT in Myelofibrosis: Long-term Results of a Prospective Phase II Clinical Trial

U Popat, RS Mehta, R Bassett, P Kongtim… - Biology of blood and …, 2020 - ncbi.nlm.nih.gov
Background: Optimal conditioning regimen for older patients with myelofibrosis undergoing
allogeneic hematopoietic cell transplantation (HCT) is not known. Likewise, role of dose …
[HTML] tctjournal.org

[HTML][HTML] Optimizing the Conditioning Regimen for Hematopoietic Cell Transplant in Myelofibrosis: Long-Term Results of a Prospective Phase II Clinical Trial

U Popat, RS Mehta, R Bassett, P Kongtim… - Biology of Blood and …, 2020 - tctjournal.org
Optimal conditioning regimens for older patients with myelofibrosis undergoing allogeneic
hematopoietic cell transplant are not known. Likewise, the role of dose intensity is not clear …

[引用][C] Optimizing the Conditioning Regimen for Hematopoietic Cell Transplant in Myelofibrosis: Long-Term Results of a Prospective Phase II Clinical Trial

U Popat, RS Mehta, R Bassett, P Kongtim… - Biology of Blood and …, 2020 - cir.nii.ac.jp
Optimizing the Conditioning Regimen for Hematopoietic Cell Transplant in Myelofibrosis:
Long-Term Results of a Prospective Phase II Clinical Trial | CiNii Research CiNii 国立情報学 …

Optimizing the Conditioning Regimen for Hematopoietic Cell Transplant in Myelofibrosis: Long-Term Results of a Prospective Phase II Clinical Trial.

U Popat, RS Mehta, R Bassett, P Kongtim… - Biology of blood and …, 2020 - escholarship.org
Optimal conditioning regimens for older patients with myelofibrosis undergoing allogeneic
hematopoietic cell transplant are not known. Likewise, the role of dose intensity is not clear …